• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. PULSE GEN MODEL 7103; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. PULSE GEN MODEL 7103; GENERATOR Back to Search Results
Model Number 7103
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Cardiac Arrest (1762)
Event Date 09/13/2022
Event Type  Injury  
Manufacturer Narrative
Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
 
Event Description
It was reported that patient was experiencing an episodic high degree ac block possibly related to stimulation.A halter monitor showed an episodic high degree av block.This event is noted as a severe and serious adverse event since it required hospitalization.The hospitalization records noted that during hospitalization the subject had episodes of av block on telemetry and appeared that the vns was activating prior to episodes of bradycardia and av block.Also, many of the episodes occurred during the night as well and it was concluded that the untreated obstructive sleep apnea (osa) was likely contributing to increased vagal tone and exacerbating the av block.The subject¿s vns was turned off and still had one additional episode of av block noted on the telemetry.It is noted as also possibly related to underlying disease since conduction disturbances often occur in patients with heart failure.No other intervention was taken for the event.No other relevant information has been received to date.
 
Event Description
Further details were learned when hospital notes were reviewed.The patient was advised to present to the hospital when review of holter monitor he was wearing as part of research protocol showed intermittent second-degree type ii heart block.Patient had a total of 3 av block episodes of longer than 3 seconds.He was not symptomatic.He continued to have episodes of av block on telemetry while admitted.His av block is likely due to increased vagal tone.It appears his vns was activating prior to his episodes of bradycardia and av block.Many of his episodes occurred during the night as well and it is likely that untreated osa is continuing to his increased vagal tone and exacerbating the av block.His vns was turned off on (b)(4) 2022.He had one additional episode of av block noted on telemetry after vns was turned off.Av block observed during overnight polysomnogram as well.Patient was asymptomatic during event and denied chest pain, worsening shortness of breath, or presyncope.While in the hospital, patient had ecgs and x-rays.Although the patient had an av block event after the disablement of the vns, the vagus nerve could have lingering effects from the last stimulation received.The outcome of this event is the patient has recovered and event has resolved.X-rays have not been reviewed by manufacturer to date.No other relevant information has been received to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 7103
Type of Device
GENERATOR
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
dana sprague
100 cyberonics blvd
suite 600
houston, TX 77058
2816672681
MDR Report Key15673220
MDR Text Key302421271
Report Number1644487-2022-01330
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/30/2022
Device Model Number7103
Device Lot Number205309
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Initial Date Manufacturer Received 10/04/2022
Initial Date FDA Received10/26/2022
Supplement Dates Manufacturer Received10/26/2022
Supplement Dates FDA Received11/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/06/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age60 YR
Patient SexMale
-
-